CUE CARD CONSULT #34

Even though patient's usually have an oncology team, keep this one in mind.

Click here and scroll down for previous newsletters.

1. Pictured Counselling Cue Card: a free sample of our counselling reference

2. Patient Consultation: exactly what a pharmacist may say to a patient picking up this medication, with formatting to show where the information is coming from on the cue card

Clearly, there are nuances that may not be captured in this format. The goal here is to provide you with an example of how a pharmacist may counsel a patient. Basic counselling tactics (e.g. showing the patient the labeled medication as you read it, having the patient repeat the information in their own words, double checking allergies, and so on) may not be depicted in the interest of keeping the content concise.

RPh: Hi! Is this medication new for you?

Patient: Yes.

RPh: Ok. What has (prescriber) told you?

Patient: They said it would help with my prostate cancer.

RPh: Ok. This medication is called ORGOVYX or RELUGOLIX, and you'll use it (as directed). It's in the family of what's called a GnRH antagonist, but basically it will reduce testosterone to help treat your prostate cancer. It can be taken with or without food, but make sure you take it at the same time each day. Do not crush or chew this medication. Handle with care; this medication is not safe to expose to anyone but you. Side effects may include hot flashes/sweating, fatigue, and muscle pain; please let us or your (prescriber) know if these become bothersome. This medication may not be right for you if you have cardiovascular disease, or diabetes. Store it at room temperature.

RPh: Did you have any questions?

Patient: You answered an important question I had already; my wife (currently pregnant) usually puts my weekly dosette together, but I'll do it now since you said it's not safe for anyone else.

RPh: Especially in pregnancy, we do not want her hormones to be affected from exposure to this med.

Patient: Thanks!

We hope you have found this useful, and please reply to this email with any feedback or topic suggestions you can. It will be the key to making this newsletter the best it can be.